We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.49B
AUM Growth
-$656M
Cap. Flow
-$84.6M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.14%
Holding
242
New
12
Increased
27
Reduced
100
Closed
17

Top Buys

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$27M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.1M
3
WAT icon
Waters Corp
WAT
+$6.41M
4
EPD icon
Enterprise Products Partners
EPD
+$3.16M
5
LH icon
Labcorp
LH
+$3.14M

Top Sells

Rank Stock Value
1
MDR
McDermott International
MDR
+$30.5M
2
SLB icon
SLB Ltd
SLB
+$24.4M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$12.9M
4
QCOM icon
Qualcomm
QCOM
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$7.5M

Sector Composition

Rank Sector Weight
1 Financials 30.05%
2 Healthcare 18.3%
3 Technology 12.11%
4 Communication Services 10.64%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$123M 4.94%
1,212,590
-70,038
-5% -$7.5M
ESGR
2
DELISTED
Enstar Group
ESGR
$121M 4.86%
723,649
-1,698
-0.2% -$307K
CACC icon
3
Credit Acceptance
CACC
$5.82B
$109M 4.37%
285,450
+593
+0.2% +$239K
BX icon
4
Blackstone
BX
$104B
$103M 4.12%
3,442,082
+8,902
+0.3% +$294K
LUMN icon
5
Lumen
LUMN
$6.43B
$97.2M 3.9%
6,415,550
-54,128
-0.8% -$1.03M
ROP icon
6
Roper Technologies
ROP
$40.4B
$96M 3.85%
360,386
-1,960
-0.5% -$554K
APO icon
7
Apollo Global Management
APO
$69B
$90.1M 3.62%
3,673,032
-121,737
-3% -$3.49M
ABT icon
8
Abbott
ABT
$188B
$86.3M 3.46%
1,192,729
-42,111
-3% -$2.96M
WAT icon
9
Waters Corp
WAT
$37.3B
$76M 3.05%
402,713
+33,730
+9% +$6.41M
MKL icon
10
Markel Group
MKL
$25.2B
$74.1M 2.97%
71,405
-543
-0.8% -$594K
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.11T
$72.9M 2.92%
1,407,180
-11,260
-0.8% -$603K
LH icon
12
Labcorp
LH
$25.2B
$64.3M 2.58%
592,615
+23,454
+4% +$3.14M
MTDR icon
13
Matador Resources
MTDR
$6.04B
$63.6M 2.55%
4,097,367
+15,221
+0.4% +$383K
JPM icon
14
JPMorgan Chase
JPM
$916B
$62.3M 2.5%
638,168
-4,319
-0.7% -$460K
TEVA icon
15
Teva Pharmaceuticals
TEVA
$40.4B
$53.8M 2.16%
3,486,872
+493,167
+16% +$10.1M
BUD icon
16
AB InBev
BUD
$164B
$49.5M 1.98%
751,805
+25,645
+4% +$1.96M
BRK.B icon
17
Berkshire Hathaway Class B
BRK.B
$1.1T
$49.3M 1.98%
241,239
-8,916
-4% -$1.86M
EPD icon
18
Enterprise Products Partners
EPD
$83.7B
$48.9M 1.96%
1,989,220
+118,148
+6% +$3.16M
JNJ icon
19
Johnson & Johnson
JNJ
$640B
$48.5M 1.95%
375,713
-15,407
-4% -$2.15M
WAB icon
20
Wabtec
WAB
$49.3B
$46.7M 1.87%
664,921
+6,513
+1% +$568K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.12T
$44.6M 1.79%
854,140
-36,100
-4% -$1.95M
QCOM icon
22
Qualcomm
QCOM
$164B
$42.7M 1.71%
750,889
-182,506
-20% -$11.1M
AWI icon
23
Armstrong World Industries
AWI
$7.37B
$41M 1.64%
704,285
+32,237
+5% +$2.06M
BAX icon
24
Baxter International
BAX
$12.8B
$35.7M 1.43%
542,957
-38,799
-7% -$2.61M
AXP icon
25
American Express
AXP
$224B
$34.1M 1.37%
358,186
-253
-0.1% -$26.5K
1
2 3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2018 Portfolio in Review

As of Q4 2018, Beck Mack & Oliver held 242 positions worth $2.49B, down 21% from $3.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Beck Mack & Oliver withdrew a net $84.6M in Q4 2018, closing 17 positions and reducing 100 holdings. Its most notable exit was McDermott International, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Beck Mack & Oliver opened a new position in Sherwin-Williams worth $26.3M.

  • Beck Mack & Oliver's largest Q4 2018 buy was Sherwin-Williams: 200,220 shares worth $26.3M.
  • Beck Mack & Oliver added most to Teva Pharmaceuticals in Q4 2018, an estimated $10.1M increase.
  • Beck Mack & Oliver's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $24.4M.
  • Beck Mack & Oliver fully exited McDermott International in Q4 2018, selling an estimated $30.5M.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $2.49B portfolio in Q4 2018.
  • Beck Mack & Oliver opened 12 new positions and closed 17 in Q4 2018.
  • Beck Mack & Oliver's portfolio value fell 21% quarter-over-quarter to $2.49B.

Based on Beck Mack & Oliver's 13F filing for Q4 2018, filed 4 Feb 2019.